Kisspeptin

Associations between kisspeptin hormone level and its genetic polymorphisms with polycystic ovary syndrome

Sex Differences in Leptin Levels in Children and Adolescents with Normal Weight and Overweight/Obesity Across Pubertal Stages: A Systematic Review and Meta-analysis

Role of serum kisspeptin as a biomarker to detect miscarriage: a systematic review and meta-analysis

An association between fat mass and obesity-associated (FTO) (rs9939609) and kisspeptin-1 (KISS-1) (rs4889, rs372790354) gene polymorphisms with polycystic ovary syndrome: an updated meta-analysis and power analysis

Diagnostic Value of Kisspeptin Levels on Early Pregnancy Outcome: a Systematic Review and Meta-analysis

Serum kisspeptin levels in polycystic ovary syndrome: A meta-analysis

Preeclampsia and gestational hypertension are associated to low maternal circulating kisspeptin levels: a systematic review and meta-analysis

Circulating kisspeptin and anti-müllerian hormone levels, and insulin resistance in women with polycystic ovary syndrome: A systematic review, meta-analysis, and meta-regression

Outcomes comparison of IVF/ICSI among different trigger methods for final oocyte maturation: A systematic review and meta-analysis

Kisspeptin Levels in Girls with Precocious Puberty: A Systematic Review and Meta-Analysis

The role of Kisspeptin levels in polycystic ovary syndrome: a systematic review and meta-analysis

Circulatory metastin/kisspeptin-1 in polycystic ovary syndrome: a systematic review and meta-analysis with diagnostic test accuracy

Intranasal kisspeptin administration rapidly stimulates gonadotropin release in humans

Kisspeptin Administration Stimulates Reproductive Hormones but Does Not Affect Anxiety in Humans

Effect of a GnRH injection on kisspeptin levels in girls with suspected precocious puberty: a randomized-controlled pilot study

Kisspeptin expression levels in patients with placenta previa: A randomized trial

Endocrine profile of the kisspeptin receptor agonist MVT-602 in healthy premenopausal women with and without ovarian stimulation: results from 2 randomized, placebo-controlled clinical tricals

Oral sodium oxybate does not alter plasma kisspeptin levels in healthy male volunteers

Effects of Kisspeptin on Sexual Brain Processing and Penile Tumescence in Men With Hypoactive Sexual Desire Disorder: A Randomized Clinical Trial

Effects of Kisspeptin Administration in Women With Hypoactive Sexual Desire Disorder: A Randomized Clinical Trial

Acute Effects of Kisspeptin Administration on Bone Metabolism in Healthy Men

Green tea catechin EGCG could prevent obesity-related precocious puberty through NKB/NK3R signaling pathway

Elinzanetant (NT-814), a Neurokinin 1,3 Receptor Antagonist, Reduces Estradiol and Progesterone in Healthy Women

Randomized Controlled Trial of Neurokinin 3 Receptor Antagonist Fezolinetant for Treatment of Polycystic Ovary Syndrome

The Effects of Kisspeptin on Brain Response to Food Images and Psychometric Parameters of Appetite in Healthy Men

Epigallocatechin gallate decreases plasma triglyceride, blood pressure, and serum kisspeptin in obese human subjects

Kisspeptin enhances brain responses to olfactory and visual cues of attraction in men

Kisspeptin and neurokinin B interactions in modulating gonadotropin secretion in women with polycystic ovary syndrome

The effects of kisspeptin on β-cell function, serum metabolites and appetite in humans

Modulations of human resting brain connectivity by kisspeptin enhance sexual and emotional functions

The Role of Kisspeptin in the Control of the Hypothalamic-Pituitary-Gonadal Axis and Reproduction.

Metabolic regulation of kisspeptin - the link between energy balance and reproduction.

Kisspeptin and Glucose Homeostasis.

Kisspeptin in the Prediction of Pregnancy Complications.

Kisspeptin as a Behavioral Hormone.

A second dose of kisspeptin-54 improves oocyte maturation in women at high risk of ovarian hyperstimulation syndrome: a Phase 2 randomized controlled trial.

Efficacy of Kisspeptin-54 to Trigger Oocyte Maturation in Women at High Risk of Ovarian Hyperstimulation Syndrome (OHSS) During In Vitro Fertilization (IVF) Therapy.

Kisspeptin-54 triggers egg maturation in women undergoing in vitro fertilization.

Divergent responses to kisspeptin in children with delayed puberty.

Kisspeptin Responsiveness Signals Emergence of Reproductive Endocrine Activity: Implications for Human Puberty.

Kisspeptin and its Current Clinical Status-A Systematic Review.

The Emerging Therapeutic Potential of Kisspeptin and Neurokinin B.

Lower circulating kisspeptin and primary hypogonadism in men with type 2 diabetes.

Kisspeptin-54 stimulates the hypothalamic-pituitary gonadal axis in human males.

Kisspeptin-54 stimulates gonadotropin release most potently during the preovulatory phase of the menstrual cycle in women.

Subcutaneous injection of kisspeptin-54 acutely stimulates gonadotropin secretion in women with hypothalamic amenorrhea, but chronic administration causes tachyphylaxis.

Twice-weekly administration of kisspeptin-54 for 8 weeks stimulates release of reproductive hormones in women with hypothalamic amenorrhea.

Kisspeptin modulates sexual and emotional brain processing in humans.

Kisspeptin treatment induces gonadotropic responses and rescues ovulation in a subset of preclinical models and women with polycystic ovary syndrome.